{"cik":"0001006281","ticker":"PLX","name":"Protalix BioTherapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"NYSE","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-03-18","last_filing_date":"2026-04-27","url":"/sec/cik-0001006281","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001975896-26-000003","form_type":"3/A","form_type_family":"insider","doc_date":"2026-04-27","title":"3/A — Protalix BioTherapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001006281/3-a/0001975896-26-000003","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001975896-26-000003-index.html"},{"accession_number":"0001426156-26-000006","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-03-30","title":"SCHEDULE 13G/A — Protalix BioTherapeutics, Inc. — 2026-03-30","url_slug":"/sec/cik-0001006281/schedule-13g-a/0001426156-26-000006","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001426156-26-000006-index.html"},{"accession_number":"0001104659-26-029846","form_type":"8-K","form_type_family":"current","doc_date":"2026-03-18","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-03-18","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-029846","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-029846-index.html"},{"accession_number":"0001104659-26-029858","form_type":"10-K","form_type_family":"annual","doc_date":"2026-03-18","title":"10-K — Protalix BioTherapeutics, Inc. — 2026-03-18","url_slug":"/sec/cik-0001006281/10-k/0001104659-26-029858","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-029858-index.html"},{"accession_number":"0001104659-26-024975","form_type":"8-K","form_type_family":"current","doc_date":"2026-03-09","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-03-09","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-024975","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-024975-index.html"},{"accession_number":"0001426156-26-000002","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-03-04","title":"SCHEDULE 13G — Protalix BioTherapeutics, Inc. — 2026-03-04","url_slug":"/sec/cik-0001006281/schedule-13g/0001426156-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001426156-26-000002-index.html"},{"accession_number":"0001104659-26-013498","form_type":"8-K","form_type_family":"current","doc_date":"2026-02-11","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-02-11","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-013498","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-013498-index.html"},{"accession_number":"0001104659-26-008410","form_type":"8-K","form_type_family":"current","doc_date":"2026-01-30","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-01-30","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-008410","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-008410-index.html"},{"accession_number":"0001104659-26-000393","form_type":"8-K","form_type_family":"current","doc_date":"2026-01-05","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-01-05","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-000393","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-000393-index.html"}],"related_endpoints":{"profile":"/sec/PLX/profile","timeline":"/sec/PLX/timeline","peers":"/sec/PLX/peers","insider_pulse":"/sec/PLX/insider-pulse","insider_summary":"/sec/PLX/insider-summary","insider_transactions":"/sec/PLX/insider-transactions","form144":"/sec/PLX/form144","holdings_as_filer":"/sec/PLX/holdings","financial_facts":"/sec/PLX/financial-facts","derivatives":"/sec/PLX/derivatives","officers":"/sec/PLX/officers","insider_network":"/sec/PLX/insider-network","risk_flags":"/sec/PLX/risk-flags","filings":"/sec/PLX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=PLX"}}